MedPath

Fulvetrant

Brand Name: Fulvetrant

Generic Name: Fulvestrant

Active
Registration Number

DRP-13158

Dosage Form

Solution For Injection (IM)

Issuance Date

July 31, 2024

Expiry Date

December 12, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/mL (250mg/5mL)
Packaging5 mL Pre-filled Syringe consisting of USP Type I Siliconized neutral glass with Elastomeric Plunger Stopper + 5 mL Polystyrene, crystal plunger rod and 5 mL Polypropylene made back stop + 21 G x 1 1/2 TW Sterile safety glide needle (Box of 2's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-estrogen
A
Application
Initial (Reconstruction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

FulvestrantActive
Monograph: Fulvestrant

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform